Open AccessAssociation between lincRNA expression and overall survival for patients with triple-negative breast cancer
Author(s) -
Jie Ping,
Shuya Huang,
Jie Wu,
PingPing Bao,
Timothy Su,
Kai Gu,
Hui Cai,
Xingyi Guo,
Loren Lipworth,
William J. Blot,
Zheng Wang,
Qiuyin Cai
Publication year - 2020
Publication title -
breast cancer research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.908
H-Index - 154
eISSN - 1573-7217
pISSN - 0167-6806
DOI - 10.1007/s10549-020-06021-6
Subject(s) - breast cancer , triple negative breast cancer , biology , gene knockdown , oncology , cancer research , overall survival , survival analysis , medicine , cancer , gene , genetics
Long intergenic non-coding RNAs (lincRNAs) are increasingly recognized as important regulators for pathogenesis and/or prognosis of breast cancer, including triple-negative breast cancer (TNBC) subtype. However, few previous studies used RNA-sequencing (RNA-Seq) technology, and none included an independent replication.